Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world. NeuroStar is the #1 TMS choice of doctors, with over 4.3 million treatments performed to date. It is an advanced treatment for depression. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target depression where it starts — the brain. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world. If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207. Please visit NeuroStar.com/Safety for full safety and prescribing information.
Looking for a particular Neuronetics, Inc. employee's phone or email?
The Neuronetics, Inc. annual revenue was $72.1 million in 2026.
Keith Sullivan is the President and CEO of Neuronetics, Inc..
197 people are employed at Neuronetics, Inc..
Neuronetics, Inc. is based in Malvern, Pennsylvania.
The NAICS codes for Neuronetics, Inc. are [54, 62111, 33, 62, 541, 621, 621111, 6211].
The SIC codes for Neuronetics, Inc. are [384, 382, 38].